Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired Paxlovid labeled for emergency use to patients through March 8, after which Paxlovid labeled for emergency use must be returned to the manufacturer or disposed of in accord with regulations, the agency said.

The FDA last May approved a new drug application for Pfizer’s Paxlovid to treat adults at high risk of progressing to severe COVID-19. Paxlovid labeled under the new drug application will continue to be authorized for emergency use to treat eligible pediatric patients, the agency said.
 

Related News Articles

Headline
The California Department of Public Health Saturday reported the first known case of clade I mpox in the U.S. to the Centers for Disease Control and Prevention…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention Nov. 6 released its annual progress report on health care-associated infections, which showed continued…
Headline
The Centers for Disease Control and Prevention Nov. 1 announced it will host two webinars this week that will address frequently asked questions regarding the…
Headline
The Department of Agriculture Oct. 30 announced the first detection of H5N1 bird flu in a pig. The positive case was found on a farm in Oregon containing a mix…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 celebrates the changing foliage, Thanksgiving and more. Download the…